Capstan Medical

Capstan Medical, established in 2020, is a medical technology company dedicated to transforming the treatment of heart valve disease. The company is developing a suite of next-generation heart valve implants, coupled with an innovative catheter-based robotic delivery platform. This groundbreaking technology aims to provide a minimally invasive alternative to traditional open-heart surgery for conditions such as mitral and tricuspid valve disorders.

Capstan Medical's approach involves a catheter-based treatment that addresses heart valve disease through a small incision in the groin, eliminating the need for stopping the heart or opening the chest, as required in open-heart surgery. This technique significantly reduces recovery times from months to weeks and makes the procedure accessible even for critically ill patients. As of January 2024, less than 2% of the over 5 million eligible patients are currently receiving treatment, leaving a rapidly growing patient population with limited options.

Capstan Medical's technology integrates surgical robotics with catheter-based technology and next-generation implants, pioneering a patient-optimized approach to heart valve repair and replacement. The company's innovative delivery system offers precise and reliable placement of the heart valve implant, minimizing the risk of complications associated with open-heart surgeries.

As of August 2023, the company secured an oversubscribed USD 31.4 million Series B investment led by Eclipse, with additional participation from Intuitive Ventures and Puma Venture Capital. This funding will enable Capstan Medical to expand its engineering, clinical development, and operations teams, advancing the technology toward the next stage of development and first human use.

Led by CEO Maggie Nixon, a two-decade veteran from Intuitive Surgical, and co-founder and CTO Dan Wallace, a seasoned robotics engineer, Capstan Medical is poised to address the rising need for minimally invasive solutions in the treatment of heart valve disease.